Roche Cobas SARS-CoV-2 Variant Set 1 Test
Roche has launched its Cobas SARS-CoV-2 Variant Set 1 Test for research use only to detect mutations in virus variants associated with increased human-to-human transmission. It detects and differentiates three mutations found in the UK B.1.1.7, South Africa B.1.351, and Brazil P.1 variants. Mutations E484K, N501Y, and del 69-70 for these variants are found in the spike protein and may be linked to increased disease transmissibility.
The RT-PCR test runs on the high-throughput Cobas 6800/8800 systems and contains the necessary primers and probes in the 384-test cassette.
Twist Bioscience Synthetic RNA Controls for SARS-CoV-2 Variants of Concern
Twist Bioscience has begun shipping new synthetic RNA reference controls for SARS-CoV-2 that include the new B.1.351 and P.1 lineages of the virus identified in South Africa and Brazil, respectively.
Twist is also now offering new stabilized synthetic RNA controls that cover the B.1.1.7 strain that can be shipped and stored at room temperature.
Codex DNA SARS-CoV-2 Synthetic Genomes for UK and South Africa Variants
Codex DNA has released full-length synthetic genomes for the emerging SARS-CoV-2 variants B.1.1.7 and B.1.351, identified in the UK and South Africa, respectively.
The genomes are synthesized de novo on Codex DNA's BioXp 3250 system and can be used in developing vaccines, therapeutics, and diagnostics for COVID-19 research. They can be activated for use in monoclonal antibody therapy or vaccine development or serve as diagnostic controls.
For more new products and services, please visit the New Products page on our website.